Watch the video “Accelerating an International Effort Led by UCSF to Identify Drug Targets for COVID-19” and like it!

As COVID-19 rapidly spread throughout the world, there became an urgent need for therapeutics to treat the infection.

Nevan Krogan, Ph.D., Professor and Director of UCSF’s QBI, quickly joined forces with an international team of scientists to map out the genome of SARS-CoV-2 and discover key interactions between the virus and over 300 human host proteins, as recently reported in Nature.

Synthego has joined this effort by leveraging its high throughput genome engineering capabilities to systematically knock these human genes out of a cell line model of infectivity - in order to validate these interactors and help identify novel and repurposed drug targets.

Learn More about UCSF’s QBI: https://qbi.ucsf.edu/qcrg

A SARS-CoV-2 protein interaction map reveals targets for drug repurposing: https://www.nature.com/articles/s41586-020-2286-9

-----

Join Future CRISPR Office Hours: https://www.synthego.com/office-hours

Learn More About Synthego: https://www.synthego.com

More About CRISPR Office Hours
Think of CRISPR Office Hours as a virtual lab meeting, an opportunity to stay connected with your peers, and a place to share alternative methods to obtain scientific information. Not all great science happens at the bench–we’ll discuss ways to keep research moving forward and minimize the impact on your lab, publications, and beyond.

We'll share insights from our customers, trends from the industry, and tips to limit the impact on your research. In a transparent, town hall-style format, we’ll take questions from Genome Engineers around the world. Most importantly, we’ll answer these questions together as a collective.

For questions, comments or to be featured as a panelist for CRISPR Office Hours, please contact us at [email protected]

Liked the “Accelerating an International Effort Led by UCSF to Identify Drug Targets for COVID-19” video?

Share it with your friends!